Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

June 6, 2025

Study Completion Date

August 31, 2026

Conditions
ALLHodgkin LymphomaCancerSurvivorship
Interventions
DEVICE

Transcranial photobiomodulation (tPBM) - Mobile System

The Vielight NeURO device delivers 810 nm near infrared light via four (4) transcranial LED modules. The LED modules target brain regions associated with a variety of cognitive functions. It can deliver light at two frequencies: Alpha (10 Hz) and Gamma (40 Hz). Alpha oscillations are prominent in healthy brains during wakeful resting and gamma oscillations are associated with activities associated with focus, memory, and cognition.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER